According to a new market research study titled ‘Epigenetics Market
to 2025 - Global Analysis and Forecasts by Product, Technology, Application and
End User. The global epigenetics market is expected to reach US$ 2,611.57 Mn in
2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of
13.6% from 2018-2025. The report highlights the trends prevalent in the global
epigenetics market and the factors driving the market along with those that act
as deterrents to its growth.
Global epigenetics market, based on technology was
segmented histone modification, DNA methylation and other technologies. In
2017, DNA methylation segment held the largest share of the market, by
technology. The largest share of the DNA methylation is primarily owing to its
ability to develop therapies for diseases including cancer, lupus, muscular
dystrophy and various congenital defects and also it helps to prevent
conditions that develop during embryonic development such as, abnormal
methylation of the X-chromosome and gene imprinting.
The market for epigenetics is expected to grow as
declining prices of sequencing, increasing prevalence of cancer, funds &
grants provided by government bodies are expected to fuel the market growth
during the forecast period. In addition, promising precise treatments by
neurogenetics are likely to have a positive impact on the growth of the market
in the coming years.
The major players operating in the epigenetics market
are Merck KGaA, Thermo Fisher Scientific Inc., ABCAM Plc, Agilent Technologies,
Active Motif, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., New England
Biolabs (NEB), and Illumina Inc. For instance, in February, 2018, QIAGEN
launches epigenetic breast cancer test in Europe. It is the first clinically
validated DNA methylation assay that helps predict the response to
anthracycline-based chemo by certain high-risk breast cancer patients.
The report
segments the global epigenetics market as follows:
Global
epigenetics Market - By Product
·
Reagents
·
Kits
·
Enzymes
·
Instruments & Consumables
·
Bioinformatics Tools
Global
epigenetics Market - By Technology
·
Histone Modification
·
DNA Methylation
·
Others
Global
epigenetics Market - By Application
·
Metabolic Diseases
·
Oncology
·
Cardiovascular Diseases
·
Others
Global
Epigenetics Market - By End User
·
Academics & Research Institutes
·
Contract Research Organizations
·
Biotechnology & Pharmaceutical Companies
Global
Epigenetics Market - By Geography
o
North America
o
U.S.
o
Canada
o
Mexico
o
Europe
o
U.K.
o
Germany
o
France
o
Asia Pacific (APAC)
o
Japan
o
China
o
India
o
Middle East & Africa (MEA)
o
South Africa
o
UAE
o
Saudi Arabia
o
South & Central America (SCAM)
o
Brazil
ABOUT
US
The Insight Partners is a one-stop industry research
provider of actionable solutions. We help our clients in getting solutions to
their research requirements through our syndicated and consulting research
services. We are specialist in industries such as Technology, Media, and
Telecommunication.
Our research model is very simple. We believe in client
servicing and delivering the best quality to our customers. Through our
research content, we are making sure that our customers get value for their
money along with better quality data and analysis.
Our research content is majorly focused towards market
trends in terms of market sizing, competitive landscaping, company analysis,
regional or country analysis, etc. We provide a detailed break-up of
segmentation in terms of geography, technology, products, and services etc.,
which helps our clients to gain a deeper analytical understanding of various
research topics.
CONTACT
US
If you have any queries about this report or would like
further information, please contact us:
North America: +1 646 491 9876
No comments:
Post a Comment